EV/EBITDA
-5.48
+0.28+4.86%
12 min ago
Summary
- As of February 7, 2025, CTNM EV/EBITDA is -5.48, with a rise of +0.28 (+4.86%) during the most recent trading day.
- CTNM EV/EBITDA is now -119.81% below its all-time high of 27.66.
Performance
CTNM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTNM EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +4.9% | -4.8% | -4.0% |
1 m1 month | +39.7% | -39.7% | -35.3% |
3 m3 months | +55.7% | -55.7% | -51.0% |
6 m6 months | +51.6% | -45.7% | -46.1% |
ytdytd | +42.5% | -42.5% | -38.0% |
1 y1 year | - | - | - |
5 y5 years | - | - | - |
CTNM EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | -9.42 | +41.8% | |
3 m | 3-month | -5.48 | at high | -13.16 | +58.4% |
6 m | 6-month | -5.48 | at high | -13.95 | +60.7% |
1 y | 1-year | 27.66 | -119.8% | -15.32 | +64.2% |
3 y | 3-year | 27.66 | -119.8% | -15.32 | +64.2% |
5 y | 5-year | 27.66 | -119.8% | -15.32 | +64.2% |
alltime | all time | 27.66 | -119.8% | -15.32 | +64.2% |
Contineum Therapeutics Class A EV/EBITDA History
Date | Value |
---|---|
2025 | -5.48(-42.5%) |
Date | Value |
---|---|
2024 | -9.53 |
FAQ
- What is Contineum Therapeutics Class A EV/EBITDA?
- What is the all time high EV/EBITDA for Contineum Therapeutics Class A?
- What is CTNM EV/EBITDA year-to-date change?
What is Contineum Therapeutics Class A EV/EBITDA?
The current EV/EBITDA of CTNM is -5.48
What is the all time high EV/EBITDA for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high EV/EBITDA is 27.66
What is CTNM EV/EBITDA year-to-date change?
Contineum Therapeutics Class A EV/EBITDA has changed by +4.05 (+42.50%) since the beginning of the year